Texas allocates $50 million to UT-led IMPACT partnership for ibogaine clinical trials treating PTSD, addiction, and more.

AI investment, water limits and major projects shape Amarillo’s growth as leaders balance development, infrastructure and ...

ChatGPT users around the world send billions of messages every week asking the chatbot for healthcare advice, OpenAI shared ...

Our shared vision is simple: sophisticated care and increased access. By integrating access, data, and clinical pathways, we will improve outcomes and the overall experience across all levels of care.

Global Vocal Biomarkers Market growth is driven by rising adoption of artificial intelligence in healthcare, increasing prevalence of neurological and mental health disorders, and growing demand for ...

Ketamine's rapid antidepressant effects have led to a significant increase in off-label psychiatric use, despite the lack of ...

Hall, a 2024 graduate, has long been fascinated by the brain-body connection. As an undergraduate, she studied the impact ...

Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic collaboration, with ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic collaborati ...

Version 1.0 of the Toolkit includes INOVAIT's Data Request Evaluation Scorecard. The Scorecard provides a structured methodology for institutions to identify and mitigate risk, capture benefits, and ...

The Global Vagus Nerve Stimulation Market Size projected to grow at a CAGR of 10.50% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the ...

A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely ...